Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Ryan Zimmerman.

Executive Summary

Alcon is making a return to the minimally invasive glaucoma surgery market by acquiring Ivantis for at least $475m, the companies said. See what BTIG analyst Ryan Zimmerman said about it here.

"Alcon has long been rumored to have an option to acquire Ivantis but there were hurdles including reimbursement, lawsuits, and other factors that delayed Alcon’s interest.” – Ryan Zimmerman, analyst, BTIG

Click here for a free trial of Medtech Insight

 

Related Content

Topics

UsernamePublicRestriction

Register

MT144703

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel